<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00591305</url>
  </required_header>
  <id_info>
    <org_study_id>RDC-008287A</org_study_id>
    <secondary_id>5R01DC008287</secondary_id>
    <nct_id>NCT00591305</nct_id>
  </id_info>
  <brief_title>New Therapy of Laryngeal Papilloma In Children</brief_title>
  <official_title>Voice Preserving Therapy of Laryngeal Papilloma In Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Deafness and Other Communication Disorders (NIDCD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will determine efficacy of a new and combined treatment of laryngeal recurrent
      respiratory papillomatosis (RRP), by using a 585 nm pulsed dye laser (PDL) and a dietary
      supplement, diindolylmethane (DIM). We will compare this new treatment with PDL-only, in a
      total of 30 children (15 of each treatment), to determine whether this combined treatment
      would be effective and safe in preventing the RRP recurrence. This is the first study to
      combine PDL technique with DIM, to develop a new, voice-preserving and long-term effective
      method of managing laryngeal RRP in children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous studies have demonstrated that PDL can be used to remove lesions on the vocal cords
      and elsewhere in the throat causing less damage to surface tissues than other commonly used
      lasers. In our proposed clinical study, we seek to compare treatment efficacy for RRP by
      combining PDL with DIM, versus PDL-only treatment, in a total of 30 children with laryngeal
      papilloma. We will determine whether this combined treatment would be effective and safe in
      preventing or delaying the RRP recurrence while preserving voice quality. 30 children will be
      divided randomly into two treatment groups, 15 in each. The experimental group will receive
      one-time PDL treatment, followed by 3-month oral administration of DIM and an additional 12
      months with no treatment. The other group will be treated with PDL-only, as a control, and
      take a placebo pill for 3 months. All of the patients will be followed for a total of 15
      months. We will compare lesion recurrence and laboratory tests between the two groups, to
      determine efficacy and safety of the new treatment. This is the first study to combine new
      PDL laser technique with DIM, to develop a new, voice-preserving and long-term effective
      method of managing laryngeal RRP in children.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    insufficient resource for recruitment
  </why_stopped>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>laser only vs laser+ a dietary agent (DIM)</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>treatment to be selected based on a randomized number table, blinded to participants</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Cases With Recurrence of Laryngeal Papilloma in 5 Months</measure>
    <time_frame>Recurrence of pailloma at 5 months</time_frame>
    <description>vocal lesion size and area after 5 month with surgery visible lesion found in &gt;50% of the treated tissue area, after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Estradiol Level in Blood Pre Treatment</measure>
    <time_frame>Before treatment at baseline</time_frame>
    <description>determine side-effect by comparing Estradiol level in blood before and after treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estradiol Level in Blood Post Treatment</measure>
    <time_frame>5 month</time_frame>
    <description>determine side-effect by comparing Estradiol level in blood before and after treatment</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Papilloma</condition>
  <arm_group>
    <arm_group_label>PDL+DIM pill</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>once-time 585 nm pulsed dye laser (PDL) treatment on the lesions, immediately followed by 3-month oral taking diindolylmethane (DIM, at 1.2-1.75mg/kg/day), in 15 subjects</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PDL+placebo pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>once-time PDL treatment on the lesions, then followed by 3-month oral taking DIM placebo, in other 15 subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>diindolylmethane (DIM)</intervention_name>
    <description>3-month DIM</description>
    <arm_group_label>PDL+DIM pill</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>585 nm pulsed dye laser</intervention_name>
    <description>once-time PDL</description>
    <arm_group_label>PDL+DIM pill</arm_group_label>
    <arm_group_label>PDL+placebo pill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 10 to 21 years of age

          2. laryngeal papillomas requiring surgical treatment

          3. willingness to participate in the study

          4. a signed informed consent form by guardian or parent

        Exclusion Criteria:

          1. age less than 10 year old, or older than 21 year

          2. guardian or parent does not understand or can not sign the consent form

          3. malignant diseases such as laryngeal cancer

          4. history of being hypersensitive to cabbage or other cruciferous vegetables

          5. pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zhi Wang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 31, 2007</study_first_submitted>
  <study_first_submitted_qc>January 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2008</study_first_posted>
  <results_first_submitted>February 24, 2017</results_first_submitted>
  <results_first_submitted_qc>May 16, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 18, 2017</results_first_posted>
  <last_update_submitted>May 16, 2017</last_update_submitted>
  <last_update_submitted_qc>May 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston University</investigator_affiliation>
    <investigator_full_name>Zhi Wang</investigator_full_name>
    <investigator_title>Professor and Director</investigator_title>
  </responsible_party>
  <keyword>papilloma</keyword>
  <keyword>PDL</keyword>
  <keyword>diindolylmethane</keyword>
  <keyword>recurrence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Papilloma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>3,3'-diindolylmethane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no such meaningful data available due to insufficient recruitment</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>5 month follow up study</recruitment_details>
      <pre_assignment_details>There was only one participant due to difficulty in recruitment which resulted in early termination of the trial.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>PDL+DIM Pill</title>
          <description>once-time 585 nm pulsed dye laser (PDL) treatment on the lesions, immediately followed by 3-month oral taking diindolylmethane (DIM, at 1.2-1.75mg/kg/day), in 15 subjects
diindolylmethane (DIM): 3-month DIM
585 nm pulsed dye laser: once-time PDL</description>
        </group>
        <group group_id="P2">
          <title>PDL+Placebo Pill</title>
          <description>once-time PDL treatment on the lesions, then followed by 3-month oral taking DIM placebo, in other 15 subjects
585 nm pulsed dye laser: once-time PDL</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>1st Follow-up in 2 Wks After Surgery</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>There was only one participant due to difficulty in recruitment which resulted in early termination of the trial.</population>
      <group_list>
        <group group_id="B1">
          <title>PDL+DIM Pill</title>
          <description>once-time 585 nm pulsed dye laser (PDL) treatment on the lesions, immediately followed by 3-month oral taking diindolylmethane (DIM, at 1.2-1.75mg/kg/day), in 15 subjects
diindolylmethane (DIM): 3-month DIM
585 nm pulsed dye laser: once-time PDL</description>
        </group>
        <group group_id="B2">
          <title>PDL+Placebo Pill</title>
          <description>once-time PDL treatment on the lesions, then followed by 3-month oral taking DIM placebo, in other 15 subjects
585 nm pulsed dye laser: once-time PDL</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1"/>
            <count group_id="B2" value="0"/>
            <count group_id="B3" value="1"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Cases With Recurrence of Laryngeal Papilloma in 5 Months</title>
        <description>vocal lesion size and area after 5 month with surgery visible lesion found in &gt;50% of the treated tissue area, after surgery</description>
        <time_frame>Recurrence of pailloma at 5 months</time_frame>
        <population>participants received at least one of two interventions</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>laser+dietary DIM</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>laser only without DIM</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Cases With Recurrence of Laryngeal Papilloma in 5 Months</title>
          <description>vocal lesion size and area after 5 month with surgery visible lesion found in &gt;50% of the treated tissue area, after surgery</description>
          <population>participants received at least one of two interventions</population>
          <units>case</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estradiol Level in Blood Pre Treatment</title>
        <description>determine side-effect by comparing Estradiol level in blood before and after treatment</description>
        <time_frame>Before treatment at baseline</time_frame>
        <population>failure for any meaningful analysis as only 1 participant in this study</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>laser+diatary DIM</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>laser only without DIM</description>
          </group>
        </group_list>
        <measure>
          <title>Estradiol Level in Blood Pre Treatment</title>
          <description>determine side-effect by comparing Estradiol level in blood before and after treatment</description>
          <population>failure for any meaningful analysis as only 1 participant in this study</population>
          <units>pg/ml</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Estradiol Level in Blood Post Treatment</title>
        <description>determine side-effect by comparing Estradiol level in blood before and after treatment</description>
        <time_frame>5 month</time_frame>
        <population>failure for any meaningful analysis as only 1 participant in this study</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention</title>
            <description>laser+diatary DIM</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>laser only without DIM</description>
          </group>
        </group_list>
        <measure>
          <title>Estradiol Level in Blood Post Treatment</title>
          <description>determine side-effect by comparing Estradiol level in blood before and after treatment</description>
          <population>failure for any meaningful analysis as only 1 participant in this study</population>
          <units>pg/ml</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months after surgery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>PDL+DIM Pill</title>
          <description>once-time 585 nm pulsed dye laser (PDL) treatment on the lesions, immediately followed by 3-month oral taking diindolylmethane (DIM, at 1.2-1.75mg/kg/day), in 15 subjects</description>
        </group>
        <group group_id="E2">
          <title>PDL+Placebo Pill</title>
          <description>once-time PDL treatment by PDL on the lesions, then followed by 3-month oral taking DIM placebo, in other 15 subjects</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>There was only one participant due to difficulty in recruitment which resulted in early termination of the trial.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Zhi Wang, MD</name_or_title>
      <organization>Boston Medical Center</organization>
      <phone>617-414-1590</phone>
      <email>zwang@bu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

